Laddar...

COMBINATION THERAPY WITH GLP-1 RECEPTOR AGONIST AND SGLT2 INHIBITOR

The SGLT2 inhibitors (SGLTi) and glucagon-like-1 receptor agonists (GLP-1 RAs) effectively reduce HbA1c, but via very different mechanisms, making them an effective duet for combination therapy. Recently, drugs in both of these antidiabetic classes have been shown to reduce cardiovascular events, mo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Obes Metab
Huvudupphovsman: DeFronzo, Ralph A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643008/
https://ncbi.nlm.nih.gov/pubmed/28432726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12982
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!